v3.26.1
Interim Condensed Consolidated Statements Of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Research and development costs, net $ 200 $ 72
General and administrative costs 381 149
Total operating expenses 581 221
Operating loss (581) (221)
Financial expenses, net (32) (9)
Equity in losses from investment in affiliate (4)
Loss before income tax (613) (234)
Tax income 35
Net loss (578) (234)
Net loss attributable to non-controlling interest (38)
Net loss attributable to the Company (540) (234)
Other comprehensive income (loss) (6) 11
Total comprehensive loss (584) (223)
Comprehensive loss attributable to non-controlling interests (59)
Comprehensive loss attributable to the Company $ (525) $ (223)
Basic loss per common stock $ (0.05) $ (0.02)
Diluted loss per common stock $ (0.05) $ (0.02)
Weighted average common stock outstanding 11,246,252 9,615,321